BioCentury
ARTICLE | Clinical News

Dyloject diclofenac sodium: Phase III started

June 5, 2006 7:00 AM UTC

JVPH began a double-blind, placebo-controlled, U.S. Phase III trial in 360 patients with moderate to severe post-operative pain following abdominal surgery. Patients will receive 18.75 mg or 37.5 mg I...